Navigation Links
VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
Date:2/24/2009

MIAMI, Feb. 24 /PRNewswire/ -- VITAS Innovative Hospice Care(R) announced today that Christopher Rieder has been named senior vice president and chief information officer. In his new position, Rieder will oversee planning and implementation of IT operations throughout VITAS to support the company's strategic direction.

Rieder has more than 20 years of IT experience with global organizations translating business objectives into technology solutions. He has worked extensively with pharmaceutical and biotechnology companies.

Rieder most recently was chief information officer and vice president at Parexel, Inc., a leading bio-pharmaceutical services organization. At Parexel, Rieder led the company's worldwide technology initiatives, including integration of technology solutions, information management and business processes. Prior to that position, Rieder served as vice president of information technology for Kos Pharmaceuticals, where he built a customer- centric IT division to improve the company's customer service operations.

"Chris's experience at the senior management level will make him a superb asset to our organization," said David Wester, VITAS president and chief financial officer. "His ability to bring a working knowledge of technology to corporate initiatives will help us continue to offer innovative solutions for providing exceptional end-of-life care to our patients and their families."

Rieder holds an MBA in information technology from American University in Washington, D.C., and a BSBA in business economics and pre-medicine from the University of Arizona. A member of the Society for Information Management, Rieder was a contributing author of the book, "Improving Technology ROI: Leading CTOs and CIOs on Making Successful Technology Investments, Maximizing Return on Investments, & Gaining a Competitive Edge (Inside the Minds)."

VITAS Innovative Hospice Care(R), a pioneer and leader in the hospice movement since 1978, is one of the nation's largest providers of end-of-life care. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 45 hospice programs in 16 states (California, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Kansas, Michigan, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin). A wholly-owned subsidiary of Chemed Corporation (NYSE: CHE), VITAS employs 9,079 professionals who care for terminally ill patients daily, primarily in the patients' homes, but also in the company's 25 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the fourth quarter of 2008, VITAS reported an average daily census of 11,627.


'/>"/>
SOURCE VITAS Innovative Hospice Care(R)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Navitas Names Dr. Dean Gesme as Medical Director
2. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
8. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
9. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract ... to improve patient outcomes and quality of life, will now be offering its ... attributed to new regulatory requirements for all new drug products, including the finalization ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
Breaking Biology Technology:
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):